- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05913934
Clubfeet and Twins and Gait Analysis
Control Gait Analysis in Clubfoot Children and Comparison With Their Healthy Twins
Children with clubfeet who were exclusively treated by Ursula Issler-Wüthrich for 3 to 14 years with manual-dynamic physiotherapy and their healthy twin siblings are compared using gait analysis.
GaitUp sensors (kinematic) and footscan V9 (kinetic) are the systems used for this comparison.
Nonparametric statistics are applied to verify aberrations.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Control gait analysis in clubfoot children and comparison with their healthy twins
Clubfeet are the most common birth defect with about 80 cases in Switzerland per year. There are two important therapies: Ponseti and manual-dynamic physiotherapy.
Ursula Issler-Wüthrich, physiotherapist, since twenty years treats exclusively clubfeet and comorbidities with clubfeet like arthrogryposis and myelomeningocele. Until today she corrected more than 400 feet with manual-dynamic physiotherapy.
Among her patients there are 11 twin pairs. In the scientific literature it is stated that in unilateral clubfoot, the other foot cannot be considered normal.With the two gait analysis systems meant for controlling the therapy results, the walking pattern of the healthy twin was compared with the pattern of the affected twin sibling.
The basis of the study is a walk over 25 meters with the GaitUp sensors (11 g) resulting in 22 quantitative digital parameters and tests on the pedobarographic plate footscan V9 leading to 10 parameters.
Statistically it will be analyzed whether there is a discrepancy between the clubfeet children and their healthy twins.
The parents in writing and the children orally gladly approved the task.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Zürich, Switzerland, 8057
- Dr.Joller BioMedical Consulting
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Twins with clubfeet
Exclusion Criteria:
- All other clubfeet
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Gait analysis parameters
Twins: Gait analysis
|
Walk over 25 meters in a gym (GaitUp) Walk over 6 meters with footscan v9 in the office
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Differences in gait analyses of treated clubfeet and their healthy twin siblings: p-value
Time Frame: 2 years
|
The gait analyses parameters are statistically compared between the healhy siblings and the clubfoot twins.
The p-values descibe the disparity among the groups.
p-values below 0.05 point to a statistical difference and are a clue to insufficient therapy.
|
2 years
|
|
Differences in gait analyses of treated clubfeet and their healthy twin siblings:Effect size
Time Frame: 2 years
|
The effect size is a measure for the interpretation of differences.
It represents the shift between the standard curves of the two populations.
Effect sizes of more than ±0.5 suggests a serious discrepancy.
|
2 years
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Peter Joller, PhD, Dr.Joller BioMedical Consulting
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ID 2023-00290
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Clubfoot
-
Cairo UniversityCompletedForefoot Adductus | Clubfoot DeformityEgypt
-
Riphah International UniversityCompleted
-
LiMingHunan Children's Hospital; Guangzhou Women and Children's Medical Center; Shenzhen...Unknown
-
Texas Scottish Rite Hospital for ChildrenRecruiting
-
University of British ColumbiaCompletedIdiopathic Clubfoot (Talipes Equinovarus)Canada
-
Washington University School of MedicineShriners Hospitals for ChildrenCompletedIsolated ClubfootUnited States
-
University of British ColumbiaCompletedIdiopathic Clubfoot (Talipes Equinovarus)Canada
-
The General Authority for Teaching Hospitals and...RecruitingManagement | Denis Brawn Brace | Modification | Idiopathic Clubfoot | Ponseti CastingEgypt
-
Guangzhou Women and Children's Medical CenterUnknown
-
Muhammad Aamir LatifRecruiting
Clinical Trials on Gait analysis
-
University of LiegeRecruitingStroke | Hemiplegic GaitBelgium
-
Agency for Healthcare Research and Quality (AHRQ)Completed
-
Henri Mondor University HospitalNot yet recruitingStroke | Walking, Difficulty | Spasticity/ParesisFrance
-
Istanbul Medipol University HospitalMedipol UniversityCompletedGait Disorders in Children | Brachial Plexus PalsyTurkey
-
Taif UniversityCairo UniversityCompleted
-
The University of Hong KongCompletedAdult Spinal DeformityHong Kong
-
University Hospital, BrestCompleted
-
Medical Corps, Israel Defense ForceAriel UniversityUnknownChronic Instability of JointIsrael
-
Bangladesh University of Engineering and TechnologyDhaka Medical CollegeRecruitingGait Impairment in Stroke PatientsBangladesh
-
Istanbul University - CerrahpasaRecruiting